1.西北民族大学,生物医学研究中心,细胞基质疫苗关键技术与产业化教育部工程研究中心,甘肃 兰州;2.西北民族大学,生物医学研究中心,甘肃省动物细胞技术创新中心,甘肃 兰州;3.西北民族大学,生物医学研究中心,生物工程与技术国家民委重点实验室,甘肃 兰州;4.西北民族大学 生命科学与工程学院,甘肃 兰州
李向茸:文献检索、论文构思和设计、初稿撰写及修改、基金资助;董平安:核心内容的修订及补充;莫荣纤:图表绘制、论文修改及讨论;冯若飞:对论文学术规范性、逻辑严谨性及全面性的审阅与修订、基金资助。
中央高校基本科研业务费专项资金(31920240125-01, 31920250002);甘肃省自然科学基金(25JRRA048);甘肃省高校教师创新基金(2025B-033);国家自然科学基金(32260037)
1.Engineering Research Center of Key Technology and Industrialization of Cell-based Vaccine, Ministry of Education, Biomedical Research Center, Northwest Minzu University, Lanzhou, Gansu, China;2.Gansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, Lanzhou, Gansu, China;3.Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, Gansu, China;4.School of Life Sciences and Engineering, Northwest Minzu University, Lanzhou, Gansu, China
This work was supported by the Fundamental Research Funds for the Central Universities (31920240125-01, 31920250002), the Natural Science Foundation of Gansu Province (25JRRA048), the Innovation Fund for University Teachers in Gansu Province (2025B-033), and the National Natural Science Foundation of China (32260037).
李向茸,董平安,莫荣纤,冯若飞. 干扰素
